CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Marvel Biosciences Reports MB-204 as Highly Effective at Treating Autism Behaviours in Shank3 Mouse Model

Data ReadoutpositiveMB-204Positive
AI Analysis

Summary

Marvel Biosciences reported that MB-204 demonstrated high effectiveness in treating autism behaviors in a Shank3 mouse model. This is a preclinical finding with limited immediate clinical relevance.

Clinical Trial Data

Outcome Details

MB-204 reported as highly effective at treating autism behaviors in Shank3 mouse model

Importance:3/10
Sentiment:
0.70
preclinicalautismmouse modelMB-204behavioral outcomes

Read the original article

Published by GlobeNewswire Clinical Studies on October 8, 2026 10:45 AM

Read Original